Osteos21 Ltd., a Chilean company owned by Cornell PhD, Hector Covacevich and krill expert Dimitri Sclabos, has launched a patent for assisting in calcium intake and deposition on bones for helping osteoporosis prevention and cure. 

This is a combination of krill and salmon processing by-products, which, properly combined with other specific ingredients helps prevent the risk of osteoporosis.

The presence of polyunsaturated fatty acids, as well as proteins rich in proline and hidroxiproline, and the fluorine from Krill, are fundamental in helping calcium deposition on bones.

The new  dietary nutraceutical organic functional supplement is free of chemicals, artificial additives, preservatives, taste or color enhancers, as well as free of heavy metals and other damaging materials.  It is also a rich source of bio- available calcium and fluorine being an excellent calcium supply ingredient.

Several end-product presentation forms have been analyzed, including a Pâté that the company said is easy to use and dose, handle and store. Furthermore it does not add the “medicine-biases” as some other treatments do and it is easy to promote through various distribution routes.

It does not need an excessive consumption rate but can be eaten as a regular pâté. It does not have counter indications and can be eaten by people of all ages.

For more information contact: tharossa@entelchile.net